IRCT2016102230421N1已完成2 期
Clinical trial comparing blood flow pulsating heart pumps to assist patients with non-pulsating flow of blood pumped during the patient's kidney function in the proximal graft surgery, coronary artery bypass grafting
Vice chancellor for research, Baqiyatallah University of Medical Sciences0 个研究点目标入组 72 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 72
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit（—）
- 性别
- All
入选标准
- •patients referred for coronary artery bypass grafting after obtaining informed consent Exclusion criteria were included: emergency patients, obese BMI greater than 40, has a history of heart surgery, a history of liver disease and impaired liver function tests and patients with insulin-dependent diabetes, kidney disease or high creatinine are excluded.
排除标准
- 未提供
研究者
相似试验
已完成
1 期
Clinical trial to measure the blood flow velocity of lower limbs during the "partial weight-bearing treadmill walking" using air pressureHealthy volunteersJPRN-UMIN000002316Motor Function Analysis, Graduate School of Medicine, Kyoto University10
招募中
不适用
Pilot Study of an Extra Aortic Counterpulsation Device acutely attached to the ascending aorta in the open chest for patients with hypertensive heart failureCardiovascularHypertensive heart failureaortic stiffnessCardiovascular - HypertensionCardiovascular - Coronary heart diseaseHypertensionACTRN12621000203853BIOQ DEVICES PTY LTD40
尚未招募
不适用
Prospective observational study of blood flow alterations in response to provocation tests and progression in ophthalmic disorders including glaucomaGlacuoma, cataract, dry eye, diabetic retinopathy, retinal vein occlusion, hypertensive retinopathyJPRN-UMIN000035273Department of Ophthalmology, Tohoku University Graduate School of Medicine300
进行中（未招募）
不适用
Clinical investigation into efficacy, hemodynamics and tolerability of simvastatin vs placebo in patients with pulmonary arterial hypertension(Shorttitle: SIPHT)Double-blind, randomized, prospective Phase III-b study for 6 months with adjusting doses of simvastatin (40/80 mg daily) or placebo followed by an open-label period with a final dose of simvastatin 80 mg daily for another 6 months - SIPHTModified NYHA class II or III patients with Pulmonary Hypertension (PH), ICD: 416.9MedDRA version: 8.1Level: LLTClassification code 10020787Term: Hypertension pulmonaryEUCTR2005-004863-41-DEDept. of Internal Medicine II, University Hospital Giessen40
已完成
不适用
A study to examine the effects of blood flow improvement and body temperature maintenance effectsHealthy IndividualsJPRN-UMIN000039180Medicial Corporation Kenshokai, Fukushima Healthcare Center36